University Graduate School of Medicine-Di (2-ethylhexyl) phthalate (DEHP) exposure is thought to lead to hepatocellular hypertrophy and hyperplasia in rodents mediated via peroxisome proliferator-activated receptor alpha (PPARα). A recent study revealed that long-term exposure to relatively low-dose DEHP (0.05%) caused liver tumors including hepatocellular carcinomas, hepatocellular adenomas, and chologiocellular carcinomas at a higher incidence in Pparα-null mice (25.8%) than in wild-type mice (10.0%). Using tissues with hepatocellular adenoma, microarray (Affymetrix MOE430A) as well as, in part, real-time quantitative PCR analysis was conducted to elucidate the mechanisms of the adenoma formation resulting from DEHP exposure in both genotyped mice. The microarray profiles showed that the up-or downregulated genes were quite different between hepatocellular adenoma tissues of wild-type and Pparα-null mice exposed to DEHP. The gene expressions of apoptotic peptidase activating factor 1 (Apaf1) and DNA-damage-inducible 45 alpha (Gadd45a) were increased in the hepatocellular adenoma tissues of wild-type mice exposed to DEHP, whereas they were unchanged in corresponding tissues of Pparα-null mice. On the other hand, the expressions of cyclin B2 and myeloid cell leukemia sequence 1 were increased only in the hepatocellular adenoma tissues of Pparα-null mice. Taken together, DEHP may induce hepatocellular adenomas, in part, via suppression of G2/M arrest regulated by Gadd45a and caspase 3-dependent apoptosis in Pparα-null mice, but these genes may not be involved in tumorigenesis in the wild-type mice. In contrast, the expression level of Met was notably increased in the liver adenoma tissue of wild-type mice, which may suggest the involvement of Met in DEHPinduced tumorigenesis in wild-type mice. (J Occup Health 2008; 50: 169-180) 
Di (2-ethylhexyl) phthalate (DEHP) is a commonly used industrial plasticizer which is used in the synthesis of plastics to improve their pliability and elasticity. These plastics are used extensively in medical devices, plastic wrap, plastic gloves, plastic food packages and other consumer products. Animal studies using DEHP have revealed toxicities including hepatocarcinogenesis 1) , and a plausible endocrine disruptive effect has also recently attracted attention. Therefore, DEHP has been replaced with alternative plasticizers such as di-isononyl phthalate. In 2002, the Ministry of Health, Labour and Welfare (MHLW) banned the use of DEHP in medical devices, baby toys and food packaging which contact fat and fatty foods directly. In 1982, the International Agency for Research on Cancer (IARC) classified DEHP in Group 2B (possibly carcinogenic to humans). However, in 2000, the IARC re-evaluated DEHP, placing it in the Group 3 category, which is for chemicals not classified as carcinogenic to humans 2) . DEHP is a representative peroxisome proliferator (PP) in rodents. PPs such as the clinically used fibrate drug clofibrate and the widely-used experimental compound Wy-14,643, increase peroxisome numbers, up-regulate peroxisomal beta-oxidation, and cause hepatocellular hypertrophy and hyperplasia when administered to rats and mice 3) . The peroxisome proliferator-activated receptor alpha (PPARα), a nuclear receptor, mediates the biological activities of PPs. In the study of wild-type and Pparα-null mice fed a diet containing 0.1% Wy-14,643 for 11 months, 100% of wild-type mice had multiple hepatocellular neoplasms, including adenomas and carcinomas, while Pparα-null mice were tumor-free 4) . Two hypotheses have been advanced to account for the mechanism of carcinogenesis by PP 3) . One is the oxidative stress hypothesis whereby increased β-oxidation induced by PP results in excessive production of reactive oxidative species (ROS) 5) leading to DNA damage and cancer 3, 6, 7) . Another hypothesis is that imbalance in hepatocyte growth control results in increased cell proliferation and suppression of apoptosis thereby disrupting hepatocyte growth control 3) . It is likely that the mechanism is a combination of ROS and altered cell proliferation. Indeed, PP-induced cell proliferation is observed in the liver of wild-type mice but not in Pparα-null mice treated with Wy-14,643. In addition, PPARα-dependent alterations in cell cycle regulatory proteins are likely to contribute to the hepatocarcinogenicity of peroxisome proliferators 8) . Apoptosis was also reported to be suppressed by the PP, nafenopin, possibly through inhibition of transforming factor-beta 1-induced apoptosis 9, 10) . Finally, a microRNA cascade under control of PPARα was found to lead to induction of c-Myc and its downstream target genes resulting in enhanced hepatocellular proliferation 11) . A recent study using the Pparα-null and wild-type mice revealed that the incidences of liver tumors including hepatocellular carcinomas, hepatocellular adenomas, and chologiocellular carcinomas were higher in Pparα-null mice exposed to DEHP than in wild-type mice 12) . In that study, the mechanism of tumorigenesis was investigated using the normal tissues of DEHP-exposed mice, and it was demonstrated that inflammation and protooncogenes altered by 0.05% DEHP-derived oxidative stresses may be involved in the tumorigenesis found in Pparα-null mice, but not in wild-type mice. However, the mechanism was not determined.
Tumorigenesis in Pparα-null mice after low-dose DEHP exposure is Pparα-independent. To determine the mechanism, we examined gene expression profiles in hepatocellular adenoma tissues as well as control livers of wild-type and Pparα-null mice using microarray data. We found the gene expression related to G2/M phase and caspase 3-dependent apoptosis pathways were different in Pparα-null and wild-type mice. Apoptotic peptidase activating factor 1 (Apaf1) and DNA-damage-inducible 45 alpha (Gadd45a) were increased only in wild-type mice. These results indicate that induction of Apaf1 and Gadd45a is inhibited in Pparα-null mice under low-dose DEHP exposure. Thus, the progression of the G2/M phase and suppression of caspase 3-dependent apoptosis may lead to PPARα-independent hepatocellular adenoma formation.
Materials and Methods

Animal experiment protocols
This study was conducted in accordance with the Guidelines for Animal Experimentation of the Shinshu University Animal Center. Pparα-null mice with a Sv/ 129 genetic background were bred as described elsewhere 13) , and with wild-type Sv/129 mice they were used to identify PPARα-dependent or -independent hepatic tumor formation caused by DEHP. All mice were housed in a temperature and light controlled environment (25°C, 12 h light/dark cycle), and maintained on stock rodent chow and tap water ad libitum. Diet containing DEHP (0.01 and 0.05%) were prepared with the rodent chow every two weeks, according to the method of Lamb et al. 14) The mice were given diets containing 0, 0.01% or 0.05% DEHP throughout the experiment (from three weeks to 22 months of age) and were sacrificed by decapitation at about 23 months of age. Livers were collected to investigate DEHP-mediated pathological changes. Small portions of livers were stored at -80°C until use. The mechanism of DEHP tumorigenesis was investigated using livers of control and hepatic tumor tissues of 0.01% and 0.05% DEHP-exposed mice with hepatocellular adenomas.
Microarray analysis
Samples of normal or hepatocellular adenoma tissue of wild-type and Pparα-null mice exposed to 0 or 0.05% DEHP, respectively, were homogenized using Mill Mixer (Qiagen, Valencia, CA, USA) and zirconium beads, and total RNA was isolated using an RNeasy kit (Qiagen). The purity of the RNA was analyzed by gel electrophoresis after confirming the 260/280 nm ratio to be between 2.0 and 2.2. Microarray analysis was conducted using GeneChip ® MOE430A probe arrays (Affymetrix, Santa Clara, CA. USA) according to the manufacturer's instructions. Superscript Choice system (Invitrogen, Carlsbad, CA, USA) and T7-(dT) 24 oligonucleotide primer (Affymetrix) were used for cDNA synthesis, cDNA Cleanup Module (Affymetrix) was used for purification, and BioArray High yield RNA Transcript Labeling Kit (Enzo Diagnostics, Farmingdale, NY, USA) for synthesis of biotin-labeled cRNA. Ten micrograms of fragmented cRNA was hybridized to a MOE430A probe array for 18 h at 45°C at 60 rpm, after which the array was washed and stained by streptavidinphycoerythrin using Fluidics Station 400 (Affymetrix) and scanned by Gene Array Scanner (Affymetrix). The digital image files were processed by Affymetrix Microarray Suite version 5.0. and the intensities were normalized for each chip by setting the mean intensity to the median (per chip normalization). The results of the DNA microarray were analyzed using GeneSpring GX 7.3 (Agilent Technologies, Santa Clara, CA, USA). The relative increase or decrease in mRNA abundance for each gene was reported as a fold-change relative to the values of normal tissue in the control group.
Real-time quantitative PCR Analysis
cDNA was synthesized from total RNA using Ominiscript Reverse Transcription (QIAGEN, Tokyo, Japan). Reverse transcription was performed on a DNA Engine Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA) using QIAGEN One Step RT-PCR Kit (QIAGEN) according to the manufacturer's instructions. Of the up-regulated or down-regulated genes obtained from microarray analysis, analyses of some specific genes thought to be related to the DEHP-induced tumorigenesis of hepatocellular adenomas were conducted by real-time quantitative PCR using GeneAmp5700 (Applied Biosystems, Foster City, CA, USA). Specific primers were generated using Primer Express software (Applied Biosystems) or purchased from TAKARA BIO (Otsu, Shiga, Japan). The following primers were generated using Primer Express software and synthesized at Operon Biotechnologies (Tokyo, Japan): myeloid cell leukemia s e q u e n c e 1 ( M c l 1 ) , 5 ' -CATTCTGGTAGAGCACCTAACACTTT-3' (forward), and 5'-CATTTACAACCCACATTAACTTGCA-3' ( r e v e r s e ) ; B c l 2 -l i k e 1 ( B c l 2 l 1 ) , 5 ' -CAGAGACTGACAGCCTGATGCT-3'(forward), and
The following primers were purchased from TAKARA BIO: Glyceraldehyde-3-phosphate dehydrogenases (GAPDH), DNA-damage-inducible 45 alpha (Gadd45a), apoptotic peptidase activating factor 1(Apaf1) and cyclin B2. Real-time quantitative PCRs were performed using SYBR Green PCR Master Mix (Applied Biosystems) or SYBR ® Premix Ex Taq TM (TAKARA BIO). A comparative threshold cycle (C T ) was used to determine gene expression relative to the control (calibrator). Hence, sample mRNA levels are expressed as n-fold differences relative to the calibrator. For each sample, the Mcl1, Bcl2l1, Gadd45a, Apaf1 and cyclin B2 C T values were normalized using the formula ∆C T =C T target gene -C T target GAPDH . To determine the relative expression levels, the following formula was used: ∆∆C T =∆ C T (1) sample -C T(1) calibrator , and the value used to plot the relative target expression was calculated using the expression 2 -∆∆C T .
Statistics
Comparisons were conducted on the real-time quantitative PCR analysis using a two-way analysis of variance, followed by Student's t-test. Values of p<0.05 were considered statistically significant.
Results
Pparα and related genes
In the Pparα-null mice, the PCR product of Pparα was not detected, whereas it was detected in the livers of wildtype mice as a 677bp amplicon (data not shown), suggesting knockout of the Pparα gene in the livers of Pparα-null mice. DEHP is known to up-regulate a gene encoding cytochrome P450, Cyp4a10, via PPARα 15) . To confirm that 0.05% DEHP activated the PPARα gene, the expression of Cyp4a10 mRNA was analyzed. In the livers of wild-type mice, 0.05% DEHP treatment upregulated the Cyp4a10 (6.7-fold), compared to the control; no induction was found in the Pparα-null mice (data not shown). However, 0.05% DEHP did not affect the expression of the other PPARα-mediated genes such as acyl-coenzyme A oxidase1 (Acox1), suggesting that this dose activated PPARα, albeit very weakly.
List of genes showing at least a 30-fold difference between adenoma and normal liver in wild-type and Pparα-null mice
In order to investigate the characteristic differences in the gene expression profiles of hepatocellular adenomas and normal tissues in wild-type or Pparα-null mice, genes that exhibited more than 30-fold differences in the microarray results were given more detailed consideration (Table 1) . Although the microscopic phenotype changes were the same (hepatocellular adenomas) in both mouse lines, the gene expression profiles were quite different, and there were no changes which were common to wildtype and Pparα-null mice. The genes listed in Table 1 were then categorized by Simplified Gene Ontology as shown in the subheading (GO Biological Process), and there were no particular pathways which were altered. These results suggest that the tumorigenesis of hepatocellular adenomas in the wild-type mice may have a mechanism different from that in Pparα-null mice.
Carcinogenesis-related genes
Alteration of particular pathways related to adenoma formation was not identified in the overall gene expression profiles in the hepatocellular adenoma tissues of both wild-type and Pparα-null mice when judged by analysis of those genes yielding 30-fold changes. Therefore, the expression levels of carcinogenesis-related genes were inspected (Table 2) . Carcinogenesis-related genes were selected according to GeneSpring's gene category, carcinogenesis and tumor suppressor genes. Surprisingly, the expression profiles of these genes were quite different between wild-type and Pparα-null mice.
The expressions of the met proto-oncogene (Met) and v-crk sarcoma virus CT10 oncogene homolog (avian)-like (Crkl) were increased only in adenoma tissue of wildtype mice. Expression of v-maf musculoaponeurotic Data are expressed as the ratio of gene expression to those of respective normal liver exposed to 0.01% DEHP in WT and 0.05% in Null (respective normal level=1). WT, hepatocellular adenoma tissues of wild-type mice; Null, hepatocellular adenoma tissues of Pparα-null mice (n=1). Genes up-regulated in at least 2-fold changes are in black, and those down-regulated at least 2-fold changes are in gray. Data are expressed as the ratio of gene expression to those of respective normal liver exposed to 0.01% DEHP in WT and 0.05% DEHP in Null (respective normal level=1). WT, hepatocellular adenoma tissues of wild-type mice; Null, hepatocellular adenoma tissues of Pparα-null mice (n=1).
fibrosarcoma oncogene family, protein B (avian) (Mafb) were decreased in that of wild-type mice, but increased in Pparα-null mice. Most tumor suppressor genes were increased in tumor tissue of wild-type mice, but decreased in that of Pparα-null mice. Only MAD homolog 4 (Smad4) was decreased in tumor tissue of wild-type mice, but increased in that of Pparα-null mice. These results suggest that decreased expression of tumor suppressor genes may be related to the increased tumorigenesis in Pparα-null mice exposed to DEHP.
G2/M phase-related genes
The cell cycle is regulated by cyclins and cyclindependent protein kinases, which play an important role in cell growth control 16, 17) . The microarray data of carcinogenicity-related genes did not reveal any typical profiles in either mouse line. Since the expressions of cyclin B1 (Ccnb1) and cyclin B2 (Ccnb2) were upregulated in tumor tissue of Pparα-null mice, G2/M phase-related genes were explored in more depth (Table  3 ). Myelin transcription factor 1(Myt1) was downregulated in tumor tissue of Pparα-null mice, but not in that of wild-type mice. In contrast, the induction levels of cyclin-dependent kinase 7 (Cdk7), growth arrest and DNA-damage-inducible 45 alpha (Gadd45a) in tumor tissue of wild-type mice were higher than those in Pparα-null mice.
Caspase 3-dependent apoptosis pathway-related genes
Apoptosis is executed via multiple pathways, all involving caspase activation 18) . Caspase 3-dependent apoptosis pathway-related genes were explored in depth. Table 4 shows expression levels of caspase 3-dependent apoptosis pathway-related genes. The expression level of Data are expressed as the ratio of gene expression to those of respective normal liver exposed to 0.01% DEHP in WT and 0.05% DEHP in Null (respective normal level=1). WT, hepatocellular adenoma tissues of wild-type mice; Null, hepatocellular adenoma tissues of Pparα-null mice (n=1). Data are expressed as the ratio of gene expression to those of respective normal liver exposed to 0.01% DEHP in WT and 0.05% DEHP in Null (respective normal level=1). WT, hepatocellular adenoma tissues of wild-type mice; Null, hepatocellular adenoma tissues of Pparα-null mice (n=1).
myeloid cell leukemia sequence 1(Mcl1) in adenoma tissue of Pparα-null mice was higher than that of wild-type mice. In contrast, expression levels of apoptotic peptidase activating factor 1(Apaf1) and caspase 3 in tumor tissue of wild-type mice were higher than in Pparα-null mice.
Real-time quantitative PCR analysis
The expressions of two mRNAs related to control of the G2/M cell cycle, cyclin B2 and Gadd45a mRNA, were measured using real-time quantitative PCR analysis (Fig.  1) . Expression of cyclin B2 mRNA was significantly up-regulated in tumor tissues of Pparα-null mice compared to the normal tissues of control mice with the same genetic background, and up-regulated in those of wild-type mice; in particular, one tumor revealed a 72-fold up-regulation. The expression of Gadd45a mRNA was significantly up-regulated in tumor tissues of wildtype mice compared to normal tissues of control mice, Fig. 1 . mRNA levels of cyclin B2, Gadd45a, Mcl1, Apaf1 and Bcl2l1 in wild-type mice livers with adenoma. mRNA levels of GAPDH mRNA, cyclin B2, Gadd45a, Mcl1, Apaf1 and Bcl2l1 were measured by real-time quantitative PCR method in normal livers (n=7) of control and hepatocellular adenoma tissues (n=3) of wild-type or Pparα-null mice exposed to 0, 0.01 or 0.05% DEHP. mRNA levels of each gene were normalized to those of GAPDH mRNA, and were expressed as an n-fold differences. Open and closed rectangles, normal liver and hepatocellular adenoma tissues of wild-type mice exposed to 0 and DEHP, respectively; open and closed circles, normal liver and hepatocellular adenoma tissues of Pparα-null mice exposed to 0 and DEHP. *Significant difference between normal and tumor tissues, p<0.05. **Significant difference between normal and tumor tissues, p<0.01.
but not in the tumor tissues of Pparα-null mice. Next, the expression of three apoptosis pathway genes, Mcl1, Apaf1, and Bcl2l1 mRNA, were also measured using the same method. In tumor tissues of Pparα-null mice, the expression of Mcl1 mRNA was significantly up-regulated compared to normal tissues of control mice with the same genetic background. In contrast, expression was down-regulated in tumor tissues of two wild-type mice, and no difference was observed in expression in wild-type mice. The expression of Apaf1 mRNA was significantly up-regulated in the tumor tissues of wildtype mice compared to normal tissues of the control group. On the contrary, there was no significant difference in the expression of these genes in Pparα-null mice. The expression of Bcl2l1 mRNA was not significantly changed between tumor and normal tissues of both Pparα-null and wild-type mice.
Discussion
Differences in tumorigenesis of relatively low-dose DEHP-induced hepatocellular adenomas between Pparα-null and wild-type mice were clearly elucidated in the current study using microarray and real-time quantitative PCR analyses. These findings suggest that DEHPinduced hepatocellular adenoma in Pparα-null mice was caused by enhanced progression at the G2/M cell cycle checkpoint and suppression of apoptosis through caspase signaling. In wild-type mice, however, these pathways might not be involved, suggesting that DEHP-induced tumorigenesis is different in the two genotyped mice. Cyclin B and cyclin D play a central role in cell cycle regulation [19] [20] [21] [22] [23] . From the microarray data in genes encoding G2/M cell cycle phase proteins, cyclin B was increased in hepatocellular adenoma tissues of Pparα-null mice. cyclin B forms a complex with Cdc2, which i s a c t i v a t e d b y d e p h o s p h o r y l a t i o n , a n d a dephosphorylated complex triggers mitosis 20, 22) . Gadd45 inhibits mitosis and promotes G2/M arrest 24, 25) . Our findings that the expression of Gadd45a was increased in the hepatocellular adenoma tissues of wild-type mice, but not in those of Pparα-null mice, suggest that activation of Cdc2/cyclin B complex was not inhibited by Gadd45a, and that hepatocyte mitosis was promoted in the tumor tissues of Pparα-null mice. However, in the tumor tissues of wild-type mice, increased Gadd45a might inhibit the activation of the Cdc2/cyclin B complex, and mitosis of hepatocyte cells might not be promoted in the tumor tissues. From the microarray data, Myt1 and p21/cip, which inhibit mitosis as well as Gadd45a, appeared to be down-regulated only in the hepatocellular adenoma tissue of Pparα-null mice. Moreover, Cdc25b, which also promotes M-phase entry, tended to be elevated in hepatocellular adenoma tissue of Pparα-null mice. These results suggest that the changes in the expression of Myt1, p21/cip and Cdc25b genes might also be related to control of the cell cycle G2/M checkpoint and enhance cell proliferation in the tumor tissues of Pparα-null mice, though these gene expressions were not reconfirmed by real-time quantitative PCR analysis. Other factors also regulate the cell cycle. Since CDK7, which promotes mitosis, increased in hepatocellular adenoma tissues of wild-type mice, but not in those of Pparα-null mice, cell proliferation in wild-type mice might partly be related to an increase in CDK7. Taken together, although cell proliferation due to enhanced mitosis may occur in the hepatocellular adenoma tissues of both mouse lines, their signaling pathways may differ.
Why cell cycle regulation was different in hepatocellular adenoma tissues of Pparα-null and those of wild-type mice could not be resolved in this study. In a previous study, PPARα suppressed DEHP-induced oxidative stress: 8-oxoguanidine (8-OHdG) levels due to DEHP exposure were higher in the livers of Pparα-null mice than those of wild-type mice, suggesting that DNA damage is induced in the livers of Pparα-null mice 12) . Nevertheless, DEHP treatment did not induce, and even appeared to down-regulate, Gadd45a in the livers of Pparα-null mice, suggesting an enhancement of the surroundings for hepatic tumorigenesis in these mice. Intraperitoneal injection of 2-nitropropane, an oxidative stress inducing agent, increased 8-OHdG levels in mouse liver tissues and also increased the p53 protein level 26) . The p53 protein is involved in DNA repair by recruiting reaper protein such as Gadd45 27) . However, there was no significant difference in up-regulation of p53 between tumor tissues of wild-type and Pparα-null mice in the current experiment (data not shown).
The mitochondrial apoptotic pathway initiates the release of cytochrome c from mitochondria. Cytochrome c activates Apaf1 protein, which in turn activates caspase 9, resulting in caspase 3-dependent cell death [28] [29] [30] . Apaf1 mRNA was induced only in hepatocellular adenoma tissues of wild-type mice, but not in those of Pparα-null mice. In addition, caspase 3 was increased 2.4-fold in adenoma tissues of wild-type mice, but not in those of Pparα-null mice, though the activity was not measured in this experiment. These results suggest that DEHP might suppress apoptosis due to an inactivation event downstream of caspase only in hepatocellular adenoma tissues of Pparα-null mice. On the other hand, DEHP up-regulated Mcl1 expression only in the tumor tissues of Pparα-null mice. Mcl1, a member of the Bcl-2 family, strongly inhibits tBid-induced cytochrome c release 31) , and delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells 32) and hematopoietic cells 33) . Short-term treatment of mice with Wy-14,643 significantly decreased the levels of anti-apoptotic Mcl1 transcript and protein in wild-type mice, but not in Pparα-null mice 34) , suggesting the involvement of PPARα in Mcl1 expression. Since the dose of DEHP used in this experiment was relatively low and activated PPARα very weakly, the effect on Mcl1 might not have been observable in the wild-type mice. However, increased Mcl1 in the hepatocellular adenoma tissues of Pparα-null mice might suppress the release of cytochrome c, which may also be involved in the suppression of caspase 3-dependent apoptosis. On the other hand, expression of Bcl2l1, which also inhibits cytochrome c release as well as Mcl1, did not differ in hepatocellular adenoma tissues of Pparα-null and wild-type mice treated with DEHP.
Of the carcinogenesis-related genes selected according to GeneSpring's gene category, 16 and 12 genes were up-regulated in liver adenoma tissue of wild-type and Pparα-null mice, respectively. However, expression levels of these genes did not change or were somewhat down-regulated in the liver tissue of Pparα-null and wildtype mice, respectively. In contrast, 5 and 1 of the expression levels of tumor suppressor genes were upregulated in liver adenoma tissue of wild-type and Pparα-null mice, respectively. It is striking that up-or downregulation of these carcinogenesis-related genes was starkly inconsistent with the two genotype mice. Although these results were obtained from microarray analysis using only one tissue of normal and adenoma in wild-type and Pparα-null mice, the gene expression differences of these genes in the two genotype mice may explain the different mechanisms of DEHP-induced tumorigenesis observed in wild-type and Pparα-null mice. Met is overexpressed in a variety of malignancies 35) and thought to be a proto-oncogene. The expression level of Met was notably increased (88-fold) in liver adenoma tissue in wild-type mice, which may suggest the in the hepatocellular adenoma tissues of Pparα-null mice exposed to DEHP, while expression of Apaf1 was induced only in those of wild-type mice, apoptosis via caspase 3 might be inhibited in the Pparα-null mice, but not in the wild-type mice.
involvement of Met in DEHP-induced tumorigenesis in wild-type mice. In this study, data obtained using microarray showed correspondence with those from real-time quantitative PCR. We handled tissues of hepatocellular adenomas obtained from two doses, 0.01 and 0.05% DEHP treatment, as samples of adenoma tissues, and analyzed them together. However, this handling did not affect data interpretation, because data obtained from RT quantitative PCR showed phenotype-, not dose-related results.
The incidence of spontaneous liver tumors in mice is rare in all strains before 12 months of age and then increases with age 36) . Frequency and liver tumor type depend on strain and sex 37) . We assume that liver tumors in Pparα-null mice resulted from DEHP exposure, because the frequencies in the DEHP-treated group were higher than in the control group. However, we could not determine whether DEHP promoted the spontaneous liver tumor in Pparα-null mice, because spontaneous hepatocellular tumors are known to occur in these mice at 24 months of age 38) . Thus, the mechanisms of spontaneous tumorigenesis may be different between Pparα-null and wild-type mice. To clarify this, gene expression profiles of liver tumors in the control group need to be analyzed.
Since neither the number of mice used in each group nor the DEHP concentrations were very high in this experiment, the samples for analyzing tumorigenesis of hepatocellular adenomas induced by DEHP were limited. In addition, we only analyzed mRNA expressions of many genes using microarray and in part real-time quantitative PCR analyses. To reconfirm the different tumorigenesis of DEHP between wild-type and Pparα-null mice reported in this manuscript, further studies are needed with an increase in animal numbers or DEHP exposure concentration, and analysis by immunohistochemical staining and/or western blot of the important genes such as Gadd45a and Apaf1, and caspase 3 activity. The results of such studies may uncover a new mechanism of tumorigenesis which is induced by DEHP.
In summary, tumorigenesis of low-dose DEHP-induced liver adenoma in Pparα-null mice might be different from that of wild-type mice, possibly involving suppression of G2/M arrest in the former which might be caused by inhibition of Gadd45a and inhibition of caspase 3-dependent apoptosis. Thus, several mechanisms of tumorigenesis of hepatocellular adenomas could be triggered by DEHP exposure in mice.
